MyHeritage Launches Health-Related Genetic Test, Ignites Debate
MyHeritage Launches Health-Related Genetic Test, Ignites Debate
Its screen for selected variants of some disease-linked genes gives customers an incomplete picture of their risk—do they know?
MyHeritage Launches Health-Related Genetic Test, Ignites Debate
MyHeritage Launches Health-Related Genetic Test, Ignites Debate

Its screen for selected variants of some disease-linked genes gives customers an incomplete picture of their risk—do they know?

Its screen for selected variants of some disease-linked genes gives customers an incomplete picture of their risk—do they know?

FDA
FDA Suspends Clinical Trials Involving Fecal Transplants
FDA Suspends Clinical Trials Involving Fecal Transplants
Chia-Yi Hou | Jun 14, 2019
The agency issued a safety warning after two patients contracted antibiotic-resistant infections and one of the patients died.
Judge Says FDA Can Stop Clinic from Selling Stem Cell Treatments
Judge Says FDA Can Stop Clinic from Selling Stem Cell Treatments
Emma Yasinski | Jun 7, 2019
The decision may facilitate the agency cracking down more effectively on the unproven interventions these companies sell.
Sunscreen Ingredients Absorbed into Blood: Study
Sunscreen Ingredients Absorbed into Blood: Study
Catherine Offord | May 7, 2019
FDA researchers report that multiple active ingredients wind up in users’ bloodstream and recommend toxicology testing to investigate the clinical significance of the findings.
FDA Lifts Import Restrictions on Genetically Engineered Salmon
FDA Lifts Import Restrictions on Genetically Engineered Salmon
Catherine Offord | Mar 11, 2019
The fast-growing fish can now be raised and sold in the US, although it’s likely to be some time before the product hits the market.
Esketamine, a Treatment for Depression, Receives FDA Approval
Esketamine, a Treatment for Depression, Receives FDA Approval
Carolyn Wilke | Mar 6, 2019
The nasal spray to ease intractable depression appears on the US market after decades without novel antidepressant treatments.
FDA Commissioner Scott Gottlieb Announces Resignation
FDA Commissioner Scott Gottlieb Announces Resignation
Jef Akst | Mar 5, 2019
Gottlieb will step down after two years at the helm of the US Food and Drug Administration to spend more time with his family.
Science Agencies to Get Boost Under New US Budget
Science Agencies to Get Boost Under New US Budget
Shawna Williams | Feb 15, 2019
The bill for fiscal year 2019 increases allocations for NSF, FDA, and others above 2018 levels.
FDA Cracks Down on “Bad Actors” in Dietary Supplement Market
FDA Cracks Down on “Bad Actors” in Dietary Supplement Market
Shawna Williams | Feb 12, 2019
The agency sends warning letters to makers of products that claim to prevent or treat Alzheimer’s and other diseases, and announces changes to its enforcement practices.
Government Shutdown Hits Funding, Resources, and Morale in Science  
Government Shutdown Hits Funding, Resources, and Morale in Science  
Carolyn Wilke | Jan 11, 2019
From missing paychecks to delayed grants to canceled travel, federal research is feeling the sting.